Which of the following are classified as small round cell tumors?
Metaplasia is thought to be caused in most cases by:
Which of the following conditions is characterized by elevated levels of Alpha-fetoprotein (AFP)?
Which of the following is true about small silencing RNAs?
Besides metastasis, which feature is most reliable in differentiating a benign from a malignant tumor?
Which of the following is an inhibitor of apoptosis?
What is the most common primary immunodeficiency?
Chediak Higashi syndrome is characterized by the following EXCEPT:
Petechiae in scurvy is due to which of the following?
The most frequent cause of clinically significant subarachnoid hemorrhage is rupture of which of the following?
Explanation: **Small Round Blue Cell Tumors (SRBCTs)** are a group of highly malignant neoplasms characterized histologically by small, undifferentiated cells with high nucleocytoplasmic ratios, dense chromatin, and scanty cytoplasm. On H&E staining, the predominant feature is the dark blue nuclei, hence the name. The correct answer is **D (All of the above)** because: 1. **Wilms’ Tumor (Nephroblastoma):** A common pediatric renal tumor that classically shows a "triphasic" pattern consisting of blastema (small round blue cells), stroma, and epithelium [1]. 2. **Retinoblastoma:** The most common intraocular tumor in children, characterized by small round cells that often form **Flexner-Wintersteiner rosettes** [1]. 3. **Rhabdomyosarcoma (specifically the Alveolar subtype):** A soft tissue sarcoma where the primitive mesenchymal cells appear as small round cells [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Differential Diagnosis (Mnemonic: MR. WELP):** * **M:** Medulloblastoma [2] * **R:** Retinoblastoma / Rhabdomyosarcoma [1], [3] * **W:** Wilms’ Tumor [1] * **E:** Ewing’s Sarcoma (often shows **Homer-Wright rosettes**) * **L:** Lymphoma (Non-Hodgkin) [4] * **P:** PNET (Primitive Neuroectodermal Tumor) / Neuroblastoma [1] * **Immunohistochemistry (IHC):** Since these tumors look identical under light microscopy, IHC is crucial for diagnosis: * **Ewing’s Sarcoma:** CD99 (MIC2) positive. * **Rhabdomyosarcoma:** Desmin and Myogenin positive [3]. * **Lymphoma:** LCA (Leukocyte Common Antigen) positive [4]. * **Neuroblastoma:** NSE and Synaptophysin positive. * **Age Factor:** These tumors are predominantly seen in the pediatric population [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 211-212. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1314-1315. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1224-1225. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 560-561.
Explanation: **Explanation:** **Metaplasia** is a reversible change in which one adult cell type (epithelial or mesenchymal) is replaced by another adult cell type. This process is a protective adaptive response to **Chronic Irritation** (Option C) [1]. When cells are subjected to a persistent stressor they cannot withstand, they reprogram themselves into a cell type better suited to survive that specific environment [2]. The underlying mechanism involves the **reprogramming of tissue stem cells** (or undifferentiated mesenchymal cells) rather than a direct transformation of already differentiated cells. This is mediated by cytokines, growth factors, and extracellular matrix components that alter the expression of transcription factors. **Analysis of Incorrect Options:** * **Genetic Mutation (A):** While mutations drive neoplasia (cancer), metaplasia is an adaptive process [1]. However, persistent metaplasia can provide a fertile soil for mutations, leading to dysplasia and eventually malignancy [3]. * **Oncogenic Virus (B):** These viruses (like HPV or EBV) typically cause cellular transformation and uncontrolled proliferation (dysplasia/neoplasia) rather than simple adaptive metaplasia. * **Immunologic Reaction (D):** Immune responses typically lead to inflammation, atrophy, or hypertrophy, but are not the primary drivers of the phenotypic switching seen in metaplasia. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Type:** Squamous metaplasia (e.g., Ciliated columnar to Squamous in the trachea of smokers) [1]. * **Barrett’s Esophagus:** A classic example of **Columnar metaplasia** (Squamous to Columnar/Goblet cells) due to chronic acid reflux [2]. * **Vitamin A Deficiency:** Can induce squamous metaplasia in the respiratory tract and eyes (Xerophthalmia) because Vitamin A is essential for normal epithelial differentiation. * **Reversibility:** Metaplasia is reversible if the irritant is removed. If the stimulus persists, it may progress to **Dysplasia** [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 91-92. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 49.
Explanation: **Explanation:** **Alpha-fetoprotein (AFP)** is a glycoprotein normally synthesized by the fetal liver and yolk sac. In adult pathology, it serves as a highly specific tumor marker for germ cell tumors (GCTs) that recapitulate these fetal structures. 1. **Why Yolk Sac Tumor is correct:** **Yolk sac tumor** (also known as Endodermal Sinus Tumor) is the most common testicular tumor in infants and young children [1]. Because it histologically mimics the fetal yolk sac, it characteristically produces high levels of AFP. A key diagnostic feature on histopathology is the **Schiller-Duval body**, which resembles a primitive glomerulus [1]. 2. **Why the other options are incorrect:** * **Seminoma:** This is the most common germ cell tumor in adults. It typically presents with elevated **hCG** (in 10-15% of cases) and **LDH**, but **AFP is never elevated** in a pure seminoma [1]. * **Teratoma:** These are composed of tissues from multiple germ layers (ectoderm, mesoderm, endoderm) [1]. While they may show minor elevations if mixed with other components, a pure teratoma is generally not associated with high AFP. * **Choriocarcinoma:** This is a highly malignant tumor characterized by the proliferation of cytotrophoblasts and syncytiotrophoblasts [1]. Its hallmark marker is a significantly elevated **beta-hCG**; AFP remains normal. **High-Yield Clinical Pearls for NEET-PG:** * **AFP** is also a primary marker for **Hepatocellular Carcinoma (HCC)** and neural tube defects (in maternal serum). * **Beta-hCG** is the marker for Choriocarcinoma and Hydatidiform mole. * **LDH** is a non-specific marker used to assess tumor burden and prognosis in GCTs. * If a patient diagnosed with "Seminoma" shows elevated AFP, it must be reclassified as a **Mixed Germ Cell Tumor** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 979-980.
Explanation: Small silencing RNAs, primarily **microRNAs (miRNAs)** and **small interfering RNAs (siRNAs)**, are short (approx. 20–30 nucleotides), non-coding RNA molecules that regulate gene expression through a process called **RNA interference (RNAi)** [1]. **Why Option B is correct:** Gene knockdown refers to the experimental technique used to reduce the expression of a specific gene. Since siRNAs can be synthetically designed to bind to specific mRNA sequences and trigger their degradation via the **RISC (RNA-Induced Silencing Complex)**, they are the cornerstone of **gene knockdown technology**. This allows researchers to study gene function by "silencing" it without altering the underlying DNA [1]. **Analysis of Incorrect Options:** * **Option A:** They are not "mature oligomers" pre-existing in the genome. They are transcribed as long primary transcripts (pri-miRNA) which must undergo processing by enzymes like **Drosha** and **Dicer** to become functional [1]. * **Option C:** **XIST** (X-inactive specific transcript) is a classic example of a **Long Non-Coding RNA (lncRNA)**, not a small RNA [3]. It plays a role in X-chromosome inactivation (Lyonization) by coating the X chromosome. * **Option D:** While microRNAs are involved in many diseases, "small silencing RNAs" as a category is a broad molecular biology term [2]. Option B is the definitive functional definition tested in pathology and genetics. **High-Yield Clinical Pearls for NEET-PG:** * **Dicer:** The ribonuclease III enzyme that cleaves precursor RNA into short active fragments [1]. * **OncomiRs:** miRNAs that function as oncogenes (e.g., by silencing tumor suppressor genes) [2]. * **Therapeutic Potential:** RNAi is being explored for treating amyloidosis and certain viral infections by silencing pathogenic proteins [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 17-18. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 230-231. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 16-17.
Explanation: **Explanation:** The hallmark of malignancy is the ability to breach natural tissue boundaries. While **metastasis** is the most definitive criterion for malignancy [1], it is often a late event. Therefore, **local invasion** is considered the most reliable feature to differentiate a malignant tumor from a benign one in a primary site [2]. * **Why Local Invasion is Correct:** Benign tumors typically grow as cohesive, expansile masses that develop a rim of condensed connective tissue (capsule). In contrast, malignant tumors are characterized by infiltrative growth, where they invade, penetrate, and destroy surrounding normal structures [2]. This lack of a capsule and the presence of irregular "claws" into adjacent tissue is the most reliable morphological sign of malignancy after metastasis. **Analysis of Incorrect Options:** * **Anaplasia:** This refers to a lack of differentiation. While a hallmark of malignancy, some highly malignant tumors may be well-differentiated, and some benign tumors can show significant cellular pleomorphism (e.g., "Ancient Schwannoma"). [1] * **Dysplasia:** This is a pre-cancerous change characterized by disordered growth and maturation [3]. It does not necessarily progress to cancer and, by definition, has not breached the basement membrane [1]. * **Metastasis:** While it is the *absolute* proof of malignancy, the question asks for the most reliable feature *besides* metastasis [1]. **NEET-PG High-Yield Pearls:** * **Exceptions to Metastasis:** Basal Cell Carcinoma (BCC) and Gliomas are highly invasive but rarely, if ever, metastasize. * **Rate of Growth:** Generally, malignant tumors grow faster than benign ones, but this is not a reliable diagnostic criterion as it is influenced by hormone levels and blood supply [2]. * **The "Gold Standard":** Histopathological examination remains the gold standard for identifying local invasion (breaching the basement membrane). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 280. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 206-207. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 209-210.
Explanation: Apoptosis (programmed cell death) is tightly regulated by the **Bcl-2 family of proteins**, which act as a rheostat to determine cell survival [3]. These proteins are categorized into two functional groups based on their effect on the mitochondrial membrane permeability [4]. **1. Why Bcl-2 is the Correct Answer:** **Bcl-2** (B-cell lymphoma 2) is the prototypical **anti-apoptotic (pro-survival)** protein [1]. It resides in the outer mitochondrial membrane and functions by preventing the leakage of Cytochrome c into the cytosol. It achieves this by neutralizing pro-apoptotic proteins like Bax and Bak, thereby maintaining mitochondrial integrity and inhibiting the intrinsic pathway of apoptosis [1]. **2. Why Other Options are Incorrect:** * **Bad (Option A):** This is a **pro-apoptotic** protein belonging to the "BH3-only" sensor group. It senses cellular stress and antagonizes anti-apoptotic proteins (like Bcl-2), promoting cell death [3]. * **Bax (Option C):** This is a **pro-apoptotic** effector protein [1]. Upon activation, Bax (along with Bak) undergoes oligomerization to form pores in the outer mitochondrial membrane (MOMP—Mitochondrial Outer Membrane Permeabilization), leading to the release of Cytochrome c and subsequent caspase activation [4]. **High-Yield NEET-PG Pearls:** * **Anti-apoptotic members:** Bcl-2, Bcl-xL, MCL-1 (Mnemonic: **B**e **C**areful **L**ive) [1]. * **Pro-apoptotic effectors:** Bax and Bak (Mnemonic: **Bax** and **Bak** "puncture" the mitochondria) [1]. * **Pro-apoptotic sensors (BH3-only):** Bad, Bim, Bid, Puma, Noxa [3]. * **Clinical Correlation:** Overexpression of Bcl-2 due to **t(14;18)** translocation is the hallmark of **Follicular Lymphoma**, where cells fail to undergo apoptosis, leading to tumor accumulation [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 310-311. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 65-67. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65.
Explanation: **Explanation:** **Isolated IgA Deficiency** is the most common primary immunodeficiency disorder, occurring in approximately 1 in 600 individuals of European descent. It is characterized by serum IgA levels less than 7 mg/dL with normal levels of IgG and IgM. The underlying defect is a failure of IgA-committed B cells to differentiate into IgA-secreting plasma cells [1]. **Analysis of Options:** * **Isolated IgA Deficiency (Correct):** Most patients are asymptomatic (clinically silent), which is why it often goes undiagnosed. When symptomatic, it presents with recurrent sinopulmonary infections and diarrhea (due to loss of mucosal immunity). * **Common Variable Immunodeficiency (CVID):** While it is the most common *clinically significant* (symptomatic) antibody deficiency, its overall prevalence is much lower than IgA deficiency [1]. * **Wiskott-Aldrich Syndrome:** This is a rare X-linked recessive disorder characterized by the triad of thrombocytopenia (small platelets), eczema, and recurrent infections [2]. * **Acquired Immunodeficiency Syndrome (AIDS):** This is a **secondary** immunodeficiency caused by HIV. The question specifically asks for a **primary** (genetic/congenital) immunodeficiency. **High-Yield NEET-PG Pearls:** 1. **Anaphylaxis Risk:** Patients with IgA deficiency are at high risk for severe anaphylactic reactions when receiving blood transfusions containing IgA, as they develop anti-IgA antibodies. 2. **Associations:** Strongly associated with autoimmune diseases (SLE, Rheumatoid Arthritis) and Celiac disease. 3. **False Positives:** Can cause false-positive pregnancy tests in some assays due to heterophile antibodies. 4. **Diagnosis:** Low IgA levels in a patient older than 4 years (to rule out transient physiological delay). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 249-250. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 250-251.
Explanation: **Explanation:** **Chediak-Higashi Syndrome (CHS)** is a rare autosomal recessive disorder caused by a mutation in the **LYST gene** (Lysosomal Trafficking Regulator) [1]. This mutation leads to defective vesicle fusion and protein trafficking [1]. **Why "Neutrophilia" is the correct answer (the exception):** Patients with CHS actually present with **Neutropenia**, not neutrophilia [1]. The defect in lysosomal trafficking interferes with normal hematopoiesis in the bone marrow, leading to ineffective granulopoiesis and the premature destruction of white blood cells. **Analysis of other options:** * **Giant Granules (Option D):** This is the morphological hallmark of CHS. Due to disordered fusion of endosomes and lysosomes, massive, non-functional "giant" granules are seen in neutrophils, eosinophils, and melanocytes [1]. * **Defective Degranulation (Option B):** The giant granules are unable to fuse properly with phagosomes [1]. This prevents the release of hydrolytic enzymes into the phagocytic vacuole. * **Delayed Microbial Killing (Option C):** Because degranulation is impaired, the delivery of bactericidal enzymes to the ingested microbe is delayed or absent, leading to recurrent pyogenic infections [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Tetrad:** 1. Oculocutaneous albinism (melanocyte defect), 2. Recurrent pyogenic infections (staphylococci/streptococci), 3. Progressive neurological defects, 4. Bleeding tendencies (platelet dense body defect) [1]. * **Diagnosis:** Peripheral blood smear showing **giant peroxidase-positive granules** in neutrophils [1]. * **Accelerated Phase:** Most patients eventually enter a "hemophagocytic lymphohistiocytosis" (HLH) phase characterized by hepatosplenomegaly and pancytopenia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 245-246.
Explanation: **Explanation:** **Correct Answer: D. Endothelial disintegration** The primary pathology in Scurvy (Vitamin C deficiency) is the impairment of **collagen synthesis**. Vitamin C (ascorbic acid) acts as a critical cofactor for the enzymes **prolyl hydroxylase** and **lysyl hydroxylase**, which are responsible for the hydroxylation of proline and lysine residues in procollagen. Without hydroxylation, collagen peptides cannot form a stable triple helix. This leads to defective type IV collagen, which is a major structural component of the **vascular basement membrane** [1] and the perivascular connective tissue. The resulting "fragility" of the vessel walls leads to **endothelial disintegration** and leakage of blood into the skin and mucous membranes, manifesting as petechiae, ecchymoses, and "corkscrew hairs" [1]. **Why other options are incorrect:** * **A & B (Platelet dysfunction/Thrombocytopenia):** While these conditions also cause petechiae [2], the platelet count and function (bleeding time) are typically **normal** in scurvy [1]. The defect is structural (vessel wall), not hematological. * **C (Clotting factor deficiency):** Clotting factors (like Factor VIII or IX) are involved in secondary hemostasis. Deficiencies usually present with deep-seated bleeds (hemarthrosis) [2] rather than superficial petechiae. **High-Yield Clinical Pearls for NEET-PG:** * **Perifollicular hemorrhages:** Pathognomonic clinical sign of Scurvy. * **Skeletal changes:** In children (Barlow’s disease), look for the **"White line of Fraenkel"** (dense zone of calcification) and **"Trummerfeld zone"** (scurvy line) on X-ray. * **Wound healing:** Significantly delayed due to the inability to form a stable collagen matrix [3]. * **Gums:** Swollen, spongy, and bleeding gums (only in patients with teeth) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 664-665. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 132. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-155.
Explanation: **Explanation:** **1. Why Saccular Aneurysm is Correct:** Saccular (berry) aneurysms are the most common cause of non-traumatic, clinically significant **Subarachnoid Hemorrhage (SAH)** [1], [2]. These are thin-walled outpocketings typically found at the arterial bifurcations in the **Circle of Willis**, most commonly at the junction of the Anterior Communicating Artery [2]. They arise due to a structural deficiency in the tunica media (congenital) combined with hemodynamic stress [1]. Rupture leads to the classic clinical presentation of a "thunderclap headache" (the worst headache of one's life). **2. Why Other Options are Incorrect:** * **Fusiform Aneurysm:** These are characterized by diffuse, circumferential dilation of a long segment of an artery (usually the basilar artery) [2]. They are more commonly associated with atherosclerosis and typically present with ischemic symptoms or mass effect rather than acute rupture/SAH [2]. * **Mycotic Aneurysm:** These result from an infected embolus (often from infective endocarditis) weakening the vessel wall [2]. While they can rupture, they are rare compared to saccular aneurysms. * **Dissecting Aneurysm:** This occurs when blood enters the wall of an artery through a structural tear [2]. In the cerebral circulation, it is a rare cause of stroke or SAH compared to the high prevalence of saccular ruptures. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Junction of Anterior Communicating Artery (30-40%) [2]. * **Associated Conditions:** Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ehlers-Danlos Syndrome, and Coarctation of the Aorta [1]. * **Risk Factors for Rupture:** Hypertension and Cigarette Smoking [1]. * **Diagnosis:** Non-contrast CT is the initial investigation of choice; Xanthochromia in CSF is seen if CT is negative but clinical suspicion is high. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 705-706. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, p. 1272.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free